| Profile | GDS4177 / 203773_x_at |
| Title | Imatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1 |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM603100 | KU-812 Imatinib-treated | 814.99 | 94 |
| GSM603099 | KU-812 non-treated | 676.71 | 92 |
| GSM603098 | KCL-22 Imatinib-treated | 747.82 | 93 |
| GSM603097 | KCL-22 non-treated | 1132.46 | 95 |
| GSM603102 | JURL-MK1 Imatinib-treated | 4663.99 | 99 |
| GSM603101 | JURL-MK1 non-treated | 3164.71 | 98 |